Yaohai Bio-Pharma provides integrated, end-to-end microbial fermentation services under the highest global GMP standards. With this combination of technology and experience, we become a reliable CRDMO partner for biotech and pharmaceutical companies that need consistent, high-quality fermentation-based production. Additionally, our production, quality analysis, and quality control teams operate within a mature GMP management system. They also receive continuous training aligned with international guidelines. As a result, every batch follows strict regulatory and quality requirements.
Scalable Fermentation Capacity
Yaohai Bio-Pharma operates five state-of-the-art fermentation lines with capacities from 50L to 2000L. This flexible and scalable setup allows projects to move smoothly from early development to commercial manufacturing. Furthermore, this system ensures consistent performance at pilot, clinical, and market scales. Therefore, clients experience reduced development risk and shorter timelines.
Diversified Fermentation Platforms
Our fermentation platforms support high-density processes for both E. coli and yeast expression systems. To further improve yield and quality, we design customized feeding strategies, induction methods, and process-control plans tailored to each project. Moreover, our real-time monitoring and optimization systems help maintain stability and reproducibility. Consequently, the whole production scale-up process becomes more efficient and predictable.
Commitment to Process Excellence
We maintain precise control over key culture parameters—including temperature, pH, aeration, and dissolved oxygen—to ensure consistent quality across every batch. Additionally, each process undergoes thorough validation to meet client specifications and global industrial standards. Through this data-driven approach, we improve efficiency, enhance yield, and minimize variability. As a result, clients receive reliable and robust fermentation outcomes at every scale.
About Yaohai Bio-Pharma
Yaohai Bio-Pharma is a CRDMO with extensive expertise in microbial expression systems. We focus on recombinant proteins, nucleic acid drugs, nanobodies, plasmid DNA, and innovative vaccines. From R&D to commercial manufacturing, we offer full-lifecycle solutions. Our mission is to build an open, integrated CRO/CDMO/MAH platform that supports global partners from discovery to market.
